Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.97

-1.0%

10:55 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (8257)	5/5/2003 6:41:28 PM
From: Icebrg	Read Replies (1) of 52153

I think this was a very interesting move from the FDA. This seems to indicate that they are lowering the bar - as far as new cancer therapies are concerned. A McLellan effect? One thing is "sure". I cannot see that they can turn down Velcade now after giving Iressa the Green Light. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next